Skip to main content
Erschienen in: Forensic Toxicology 1/2015

01.01.2015 | Original Article

Hair analysis for JWH-018, JWH-122, and JWH-210 after passive in vivo exposure to synthetic cannabinoid smoke

verfasst von: Melanie Hutter, Bjoern Moosmann, Volker Auwärter, Merja A. Neukamm

Erschienen in: Forensic Toxicology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Hair analysis is often used to confirm abstinence from drug use. However, interpretation of hair analysis results can be challenging, particularly with regard to smoked substances like synthetic cannabinoids, because hair can be contaminated by side-stream smoke. In this study, we measured the concentrations of synthetic cannabinoids in scalp hair after exposure to side-stream smoke from a cigarette containing the synthetic cannabinoids JWH-018, JWH-122, and JWH-210. Three participants exposed their hair to the side-stream smoke once each working day for 3 weeks to mimic realistic conditions experienced by consumers of these drugs. Two other participants exposed their hair once to the side-stream smoke of one cigarette. Scuba regulators with external air supply were used to avoid inhalation of smoke. Hair segments and wash solutions were analyzed by liquid chromatography–tandem mass spectrometry. The highest measured concentrations were 70 pg/mg of JWH-018, 260 pg/mg of JWH-122, and 950 pg/mg of JWH-210 in distal hair segments collected at the end of the exposure period. At 2–3 weeks after the end of the repeated exposure, all three synthetic cannabinoids were detected in the hair samples of both participants with longer hair. In these samples, the ratio of cannabinoid amount in acetone wash to that in hair was below 0.5 for all synthetic cannabinoids, which could be interpreted as evidence of consumption. However, with the nonconsumption of synthetic cannabinoids by our study participants being confirmed by urine testing, it is apparent that even high substance concentrations in hair samples do not prove consumption and can be explained by external contamination after contact with synthetic cannabinoids alone.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Tsanaclis L, Wicks JF (2008) Differentiation between drug use and environmental contamination when testing for drugs in hair. Forensic Sci Int 176:19–22PubMedCrossRef Tsanaclis L, Wicks JF (2008) Differentiation between drug use and environmental contamination when testing for drugs in hair. Forensic Sci Int 176:19–22PubMedCrossRef
2.
Zurück zum Zitat Moosmann B, Roth N, Auwärter V (2014) Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke. Drug Test Anal 6:119–125PubMedCrossRef Moosmann B, Roth N, Auwärter V (2014) Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke. Drug Test Anal 6:119–125PubMedCrossRef
3.
Zurück zum Zitat Auwärter V, Wohlfarth A, Traber J, Thieme D, Weinmann W (2010) Hair analysis for Δ9-tetrahydrocannabinolic acid A—new insights into the mechanism of drug incorporation of cannabinoids into hair. Forensic Sci Int 196:10–13PubMedCrossRef Auwärter V, Wohlfarth A, Traber J, Thieme D, Weinmann W (2010) Hair analysis for Δ9-tetrahydrocannabinolic acid A—new insights into the mechanism of drug incorporation of cannabinoids into hair. Forensic Sci Int 196:10–13PubMedCrossRef
4.
Zurück zum Zitat Moosmann B, Roth N, Hastedt M, Jacobsen-Bauer A, Pragst F, Auwärter V (2014) Cannabinoid findings in children hair––what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Δ9-tetrahydrocannabinolic acid A concentrations. Drug Test Anal. doi:10.1002/dta.1692 Moosmann B, Roth N, Hastedt M, Jacobsen-Bauer A, Pragst F, Auwärter V (2014) Cannabinoid findings in children hair––what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Δ9-tetrahydrocannabinolic acid A concentrations. Drug Test Anal. doi:10.​1002/​dta.​1692
5.
Zurück zum Zitat Hutter M, Kneisel S, Auwärter V, Neukamm MA (2012) Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. J Chromatogr B 903:95–101CrossRef Hutter M, Kneisel S, Auwärter V, Neukamm MA (2012) Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. J Chromatogr B 903:95–101CrossRef
6.
Zurück zum Zitat Salomone A, Gerace E, D’Urso F, Di Corcia D, Vincenti M (2012) Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples. J Mass Spectrom 47:604–610PubMedCrossRef Salomone A, Gerace E, D’Urso F, Di Corcia D, Vincenti M (2012) Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples. J Mass Spectrom 47:604–610PubMedCrossRef
7.
Zurück zum Zitat Kim J, In S, Park Y, Park M, Kim E, Lee S (2013) Deposition of JWH-018, JWH-073 and their metabolites in hair and effect of hair pigmentation. Anal Bioanal Chem 405:9769–9778PubMedCrossRef Kim J, In S, Park Y, Park M, Kim E, Lee S (2013) Deposition of JWH-018, JWH-073 and their metabolites in hair and effect of hair pigmentation. Anal Bioanal Chem 405:9769–9778PubMedCrossRef
8.
Zurück zum Zitat Salomone A, Luciano C, Di Corcia D, Gerace E, Vincenti M (2014) Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers. Drug Test Anal 6:126–134PubMedCrossRef Salomone A, Luciano C, Di Corcia D, Gerace E, Vincenti M (2014) Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers. Drug Test Anal 6:126–134PubMedCrossRef
9.
Zurück zum Zitat Gottardo R, Sorio D, Musile G, Trapani E, Seri C, Serpelloni G, Tagliaro F (2013) Screening for synthetic cannabinoids in hair by using LC-QTOF MS: a new and powerful approach to study the penetration of these new psychoactive substances in the population. Med Sci Law 54:22–27PubMedCrossRef Gottardo R, Sorio D, Musile G, Trapani E, Seri C, Serpelloni G, Tagliaro F (2013) Screening for synthetic cannabinoids in hair by using LC-QTOF MS: a new and powerful approach to study the penetration of these new psychoactive substances in the population. Med Sci Law 54:22–27PubMedCrossRef
11.
Zurück zum Zitat Cooper GA, Kronstrand R, Kintz P (2012) Society of hair testing guidelines for drug testing in hair. Forensic Sci Int 218:20–24PubMedCrossRef Cooper GA, Kronstrand R, Kintz P (2012) Society of hair testing guidelines for drug testing in hair. Forensic Sci Int 218:20–24PubMedCrossRef
12.
Zurück zum Zitat Thorspecken J, Skopp G, Pötsch L (2004) In vitro contamination of hair by marijuana smoke. Clin Chem 50:596–602PubMedCrossRef Thorspecken J, Skopp G, Pötsch L (2004) In vitro contamination of hair by marijuana smoke. Clin Chem 50:596–602PubMedCrossRef
13.
Zurück zum Zitat Miller EI, Murray GJ, Rollins DE, Tiffany ST, Wilkins DG (2011) Validation of a liquid chromatography-tandem mass spectrometry method for the detection of nicotine biomarkers in hair and an evaluation of wash procedures for removal of environmental nicotine. J Anal Toxicol 35:321–332PubMedCrossRef Miller EI, Murray GJ, Rollins DE, Tiffany ST, Wilkins DG (2011) Validation of a liquid chromatography-tandem mass spectrometry method for the detection of nicotine biomarkers in hair and an evaluation of wash procedures for removal of environmental nicotine. J Anal Toxicol 35:321–332PubMedCrossRef
14.
Zurück zum Zitat Auwärter V, Dresen S, Weinmann W, Mueller M, Puetz M, Ferreiros N (2009) ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832–837PubMedCrossRef Auwärter V, Dresen S, Weinmann W, Mueller M, Puetz M, Ferreiros N (2009) ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832–837PubMedCrossRef
15.
Zurück zum Zitat Nakajima J, Takahashi M, Seto T, Kanai C, Suzuki J, Yoshida M, Hamano T (2011) Identification and quantitation of two benzoylindoles AM-694 and (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone, and three cannabimimetic naphthoylindoles JWH-210, JWH-122, and JWH-019 as adulterants in illegal products obtained via the Internet. Forensic Toxicol 29:95–110CrossRef Nakajima J, Takahashi M, Seto T, Kanai C, Suzuki J, Yoshida M, Hamano T (2011) Identification and quantitation of two benzoylindoles AM-694 and (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone, and three cannabimimetic naphthoylindoles JWH-210, JWH-122, and JWH-019 as adulterants in illegal products obtained via the Internet. Forensic Toxicol 29:95–110CrossRef
16.
Zurück zum Zitat Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y (2009) Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol 27:61–66CrossRef Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y (2009) Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol 27:61–66CrossRef
17.
Zurück zum Zitat Kneisel S, Auwärter V (2012) Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J Mass Spectrom 47:825–835PubMedCrossRef Kneisel S, Auwärter V (2012) Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J Mass Spectrom 47:825–835PubMedCrossRef
18.
Zurück zum Zitat Hutter M, Broecker S, Kneisel S, Auwärter V (2012) Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in ‘herbal mixtures’ using LC-MS-MS techniques. J Mass Spectrom 47:54–65PubMedCrossRef Hutter M, Broecker S, Kneisel S, Auwärter V (2012) Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in ‘herbal mixtures’ using LC-MS-MS techniques. J Mass Spectrom 47:54–65PubMedCrossRef
19.
Zurück zum Zitat Moosmann B, Valcheva T, Neukamm MA, Angerer V, Auwärter V (2014) Hair analysis of synthetic cannabinoids: does handling of herbal mixtures affect the analyst’s hair concentration? Forensic Toxicol. doi:10.1007/s11419-014-0244-7 Moosmann B, Valcheva T, Neukamm MA, Angerer V, Auwärter V (2014) Hair analysis of synthetic cannabinoids: does handling of herbal mixtures affect the analyst’s hair concentration? Forensic Toxicol. doi:10.​1007/​s11419-014-0244-7
20.
Zurück zum Zitat Pragst F, Balikova MA (2006) State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta 370:17–49PubMedCrossRef Pragst F, Balikova MA (2006) State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta 370:17–49PubMedCrossRef
21.
Zurück zum Zitat Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, Beuerle T (2009) Spice: a never ending story? Forensic Sci Int 191:58–63PubMedCrossRef Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, Beuerle T (2009) Spice: a never ending story? Forensic Sci Int 191:58–63PubMedCrossRef
Metadaten
Titel
Hair analysis for JWH-018, JWH-122, and JWH-210 after passive in vivo exposure to synthetic cannabinoid smoke
verfasst von
Melanie Hutter
Bjoern Moosmann
Volker Auwärter
Merja A. Neukamm
Publikationsdatum
01.01.2015
Verlag
Springer Japan
Erschienen in
Forensic Toxicology / Ausgabe 1/2015
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-014-0251-8

Weitere Artikel der Ausgabe 1/2015

Forensic Toxicology 1/2015 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie